21246-full
Jorpatabi
Sex: F
Data Quality: 0 stars
MS: 4 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Mild
Cognition: moderate
Vision: mild
Speech: mild
Swallowing: mild
Upper limb: mild
Walking: moderate
Jorpatabi
Female, 38 years
TX, United States
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Jorpatabi's Glatiramer acetate is for:

  • MS

Jorpatabi's side effects of Glatiramer acetate:

Jorpatabi's Glatiramer acetate History (Stopped)
20 mg Daily Aug 17, 2009 - Oct 11, 2010
Stopped Did not seem to work and Personal research Oct 11, 2010
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Oct 11, 2010 20 mg Daily ? MildMildMildMild UsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhat
Apr 17, 2010 20 mg Daily Led_efficacy_2Led_efficacy_2Led_defaultLed_default NoneNoneNoneNone UsuallyUsuallyUsuallyUsually A littleA littleA littleA little
Date
Apr 17, 2010
Advice & Tips
The most difficult part is just taking it every day. I don't like shots, so I have to look past it and think of my family. I had to start a new job with late hours, so then the biggest obstacle was when to take the meds. I ended up not doing it for a couple of months, then another relapse started. I have promised my doctor, my husband, and my best friend that I will not stop the meds again. My best friend told me if I missed mine, she wasn't going to take her meds that she has been on since high school. So now I email/text her every day to let her know I have taken my shot the night before.
Cost
< $25 monthly

About Glatiramer acetate (Prescription Drug)

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Learn more about Glatiramer acetate in our Glatiramer acetate Community Report.